NCT04397614View on ClinicalTrials.gov

Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

November 12, 2021

Study Completion Date

November 12, 2021

Conditions
Sars-CoV2Covid-19
Interventions
OTHER

mHealth Assessments

Daily symptom tracker

Trial Locations (1)

73104

Stephenson Cancer Center, Oklahoma City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Oklahoma

OTHER

NCT04397614 - Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients | Biotech Hunter | Biotech Hunter